Floyd Robert Michael 4
4 · Processa Pharmaceuticals, Inc. · Filed Apr 11, 2022
Insider Transaction Report
Form 4
Floyd Robert Michael
Chief Operating Officer
Transactions
- Award
Restricted Stock Units
2022-04-01+247,841→ 302,766 totalExercise: $0.00→ Common Stock (247,841 underlying)
Footnotes (2)
- [F1]Restricted Stock Units (RSUs) vest upon achievement of certain performance goals. The grant of 136,632 RSUs are subject to shareholder approval of the Issuer's 2019 Omnibus Incentive Plan (the "Plan") to increase the authorized shares under the Plan.
- [F2]The previous filing understated this number. This new total accurately reflects the cumulative total of Restricted Stock Units for the reporting person.